Analysts' outlook on Coherus BioSciences turns pessimistic w...

Analysts' outlook on Coherus BioSciences turns pessimistic with a significant cut to revenue estimates. Despite predicting faster revenue growth than the market, the drastic downgrade for next year's forecasts raises concerns about future performance.